BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

452 related articles for article (PubMed ID: 33404696)

  • 1. Radiomic analysis of HTR-DCE MR sequences improves diagnostic performance compared to BI-RADS analysis of breast MR lesions.
    Perre SV; Duron L; Milon A; Bekhouche A; Balvay D; Cornelis FH; Fournier L; Thomassin-Naggara I
    Eur Radiol; 2021 Jul; 31(7):4848-4859. PubMed ID: 33404696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-temporal resolution DCE-MRI improves assessment of intra- and peri-breast lesions categorized as BI-RADS 4.
    Liu Y; Wang S; Qu J; Tang R; Wang C; Xiao F; Pang P; Sun Z; Xu M; Li J
    BMC Med Imaging; 2023 Apr; 23(1):58. PubMed ID: 37076817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abbreviated breast MRI combining FAST protocol and high temporal resolution (HTR) dynamic contrast enhanced (DCE) sequence.
    Milon A; Vande Perre S; Poujol J; Trop I; Kermarrec E; Bekhouche A; Thomassin-Naggara I
    Eur J Radiol; 2019 Aug; 117():199-208. PubMed ID: 31307648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiomics Based on DCE-MRI Improved Diagnostic Performance Compared to BI-RADS Analysis in Identifying Sclerosing Adenosis of the Breast.
    Ruan M; Ding Z; Shan Y; Pan S; Shao C; Xu W; Zhen T; Pang P; Shen Q
    Front Oncol; 2022; 12():888141. PubMed ID: 35646630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adding a Model-free Diffusion MRI Marker to BI-RADS Assessment Improves Specificity for Diagnosing Breast Lesions.
    Goto M; Le Bihan D; Yoshida M; Sakai K; Yamada K
    Radiology; 2019 Jul; 292(1):84-93. PubMed ID: 31112086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic performance of initial enhancement analysis using ultra-fast dynamic contrast-enhanced MRI for breast lesions.
    Goto M; Sakai K; Yokota H; Kiba M; Yoshida M; Imai H; Weiland E; Yokota I; Yamada K
    Eur Radiol; 2019 Mar; 29(3):1164-1174. PubMed ID: 30088064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An A.I. classifier derived from 4D radiomics of dynamic contrast-enhanced breast MRI data: potential to avoid unnecessary breast biopsies.
    Pötsch N; Dietzel M; Kapetas P; Clauser P; Pinker K; Ellmann S; Uder M; Helbich T; Baltzer PAT
    Eur Radiol; 2021 Aug; 31(8):5866-5876. PubMed ID: 33744990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diffusion tensor imaging for characterizing tumor microstructure and improving diagnostic performance on breast MRI: a prospective observational study.
    Luo J; Hippe DS; Rahbar H; Parsian S; Rendi MH; Partridge SC
    Breast Cancer Res; 2019 Sep; 21(1):102. PubMed ID: 31484577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentiation between subcentimeter carcinomas and benign lesions using kinetic parameters derived from ultrafast dynamic contrast-enhanced breast MRI.
    Onishi N; Sadinski M; Gibbs P; Gallagher KM; Hughes MC; Ko ES; Dashevsky BZ; Shanbhag DD; Fung MM; Hunt TM; Martinez DF; Shukla-Dave A; Morris EA; Sutton EJ
    Eur Radiol; 2020 Feb; 30(2):756-766. PubMed ID: 31468162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiparametric MRI model with dynamic contrast-enhanced and diffusion-weighted imaging enables breast cancer diagnosis with high accuracy.
    Zhang M; Horvat JV; Bernard-Davila B; Marino MA; Leithner D; Ochoa-Albiztegui RE; Helbich TH; Morris EA; Thakur S; Pinker K
    J Magn Reson Imaging; 2019 Mar; 49(3):864-874. PubMed ID: 30375702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The additional utility of ultrafast MRI on conventional DCE-MRI in evaluating preoperative MRI of breast cancer patients.
    Lee SJ; Ko KH; Jung HK; Koh JE; Park AY
    Eur J Radiol; 2020 Mar; 124():108841. PubMed ID: 31981877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiomic and Artificial Intelligence Analysis with Textural Metrics Extracted by Contrast-Enhanced Mammography and Dynamic Contrast Magnetic Resonance Imaging to Detect Breast Malignant Lesions.
    Fusco R; Di Bernardo E; Piccirillo A; Rubulotta MR; Petrosino T; Barretta ML; Mattace Raso M; Vallone P; Raiano C; Di Giacomo R; Siani C; Avino F; Scognamiglio G; Di Bonito M; Granata V; Petrillo A
    Curr Oncol; 2022 Mar; 29(3):1947-1966. PubMed ID: 35323359
    [No Abstract]   [Full Text] [Related]  

  • 13. Quantitative DWI implemented after DCE-MRI yields increased specificity for BI-RADS 3 and 4 breast lesions.
    Dijkstra H; Dorrius MD; Wielema M; Pijnappel RM; Oudkerk M; Sijens PE
    J Magn Reson Imaging; 2016 Dec; 44(6):1642-1649. PubMed ID: 27273694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Computer-Aided Diagnosis in Multiparametric Magnetic Resonance Imaging Screening of Women With Extremely Dense Breasts to Reduce False-Positive Diagnoses.
    Verburg E; van Gils CH; Bakker MF; Viergever MA; Pijnappel RM; Veldhuis WB; Gilhuijs KGA
    Invest Radiol; 2020 Jul; 55(7):438-444. PubMed ID: 32149858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Artificial Intelligence Applied to Breast MRI for Improved Diagnosis.
    Jiang Y; Edwards AV; Newstead GM
    Radiology; 2021 Jan; 298(1):38-46. PubMed ID: 33078996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The value of noncontrast MRI in evaluating breast imaging reporting and data system category 0 lesions on digital mammograms.
    Zhang R; Xu M; Zhou C; Ding X; Lu H; Ge M; Du L; Bu Y
    Quant Imaging Med Surg; 2022 Aug; 12(8):4069-4080. PubMed ID: 35919041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved value of whole-lesion histogram analysis on DCE parametric maps for diagnosing small breast cancer (≤ 1 cm).
    Xie T; Zhao Q; Fu C; Grimm R; Gu Y; Peng W
    Eur Radiol; 2022 Mar; 32(3):1634-1643. PubMed ID: 34505195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Kaiser score reliably excludes malignancy in benign contrast-enhancing lesions classified as BI-RADS 4 on breast MRI high-risk screening exams.
    Milos RI; Pipan F; Kalovidouri A; Clauser P; Kapetas P; Bernathova M; Helbich TH; Baltzer PAT
    Eur Radiol; 2020 Nov; 30(11):6052-6061. PubMed ID: 32504098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of Synthetic Relaxometry and Diffusion Measures in the Differentiation of Benign and Malignant Breast Lesions as Compared to BI-RADS.
    Gao W; Zhang S; Guo J; Wei X; Li X; Diao Y; Huang W; Yao Y; Shang A; Zhang Y; Yang Q; Chen X
    J Magn Reson Imaging; 2021 Apr; 53(4):1118-1127. PubMed ID: 33179809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative evaluation of Kaiser score in diagnosing breast dynamic contrast-enhanced magnetic resonance imaging for patients with high-grade background parenchymal enhancement.
    Wang H; Gao L; Chen X; Wang SJ
    Quant Imaging Med Surg; 2023 Oct; 13(10):6384-6394. PubMed ID: 37869283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.